Hims & Hers Health, Inc. (HIMS) closed at $28.89 in the latest trading session, marking a -5.19% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 1.16% for the day. On the other hand, the Dow registered a gain of 1.21%, and the technology-centric Nasdaq increased by 1.18%.
The company's stock has dropped by 12.44% in the past month, falling short of the Medical sector's loss of 1.32% and the S&P 500's loss of 0.42%.
Analysts and investors alike will be keeping a close eye on the performance of Hims & Hers Health, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.04, reflecting a 63.64% decrease from the same quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $620.41 million, indicating a 28.94% upward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.48 per share and a revenue of $2.35 billion, signifying shifts of +77.78% and 0%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Hims & Hers Health, Inc. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been a 4.52% fall in the Zacks Consensus EPS estimate. Hims & Hers Health, Inc. is currently a Zacks Rank #4 (Sell).
In terms of valuation, Hims & Hers Health, Inc. is currently trading at a Forward P/E ratio of 54.07. For comparison, its industry has an average Forward P/E of 27.28, which means Hims & Hers Health, Inc. is trading at a premium to the group.
We can additionally observe that HIMS currently boasts a PEG ratio of 5.16. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Medical Info Systems stocks are, on average, holding a PEG ratio of 2.27 based on yesterday's closing prices.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 161, this industry ranks in the bottom 35% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow HIMS in the coming trading sessions, be sure to utilize Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hims & Hers Health, Inc. (HIMS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
